From April, medicines for myasthenia patients will be fully reimbursed
Myasthenia gravis is a rare, chronic, autoimmune neuromuscular disease characterized by weakness of various muscle groups. The disease significantly reduces the patients’ quality of life, in severe cases the weakness also affects the respiratory muscles, and the patient is actually unable to breathe on his own – death occurs without hospitalization and intensive therapy. Also, … Read more